BMJ 1998;317:702 ( 12 September )

News

Concern raised about performance enhancing drugs in the US

Deborah Josefson, San Francisco

The race between two US baseball players to achieve a record number of home runs in one season has focused US national attention on the increasing use of performance enhancing dietary supplements by athletes.

Baseball players Mark Mc-Gwire and Sammy Sosa have admitted consuming creatine, an energy boosting protein. Mark McGwire also admits to taking androstenedione, a testosterone precursor. Both substances are readily available over the counter, and because they are labelled as dietary supplements they are not subject to regulation by the Food and Drug Administration.

The enthusiastic endorsement of such substances by high profile professional athletes has raised their popularity among teenagers, college athletes, and amateur athletes. It has also led to more inquiries into the safety of such supplements.

Androstenedione, a potent anabolic steroid, is produced endogenously in small quantities in the adrenal glands and gonads. In turn, it is converted by the liver to testosterone, an even more potent androgen. In large doses, anabolic steroids have been implicated in causing liver cancers, aggressive behaviour, gynaecomastia, and testicular atrophy.

Whereas testosterone is available on prescription only, androstenedione can be easily purchased over the counter. No long term studies have been done on androstenedione supplementation, but it seems likely that side effects would mirror those of testosterone. Children taking such steroids may be subject to an increased incidence of hepatomas, cystic acne, and early epiphyseal closure leading to stunted growth.

Several athletic organisations, including the International Olympic Committee, the National College Athletic Association, and the National Football League, have banned the use of androstenedione by their members. But, finding offenders is difficult, as the steroid is not tested for in standard drug tests.

Manufacturers of androstenedione maintain that the steroid is safe, and that it only transiently raises testosterone levels and only by up to 15%. Users and manufacturers claim that it allows them to build muscle mass quickly and recover rapidly from injury.

Creatine, the other popular muscle builder, is less controversial than androstenedione, but even less is known about its side effects. Creatine is naturally present in muscle, brain, and blood cells. It is believed to enhance athletic performance by recycling ADP to ATP and stemming lactic acidosis, allowing cells to recover faster from exertion. Accordingly, creatine users report less fatigue and increased endurance and muscle strength. Intracellular fluid retention is also increased by creatine.

The daily creatine requirement is believed to be about 2 g for a 70 kg person and is usually consumed in red meat and fish as well as being produced endogenously. People who use creatine supplements typically "load" on the protein for a week, consuming 20-25 g daily. They then continue with a maintenance dose of 5 g a day. This is thought to ensure a continuous supply of creatine in the muscles.

Many professional ball players, however, take the supplement in even larger doses. There have been few studies on the safety of creatine, but so far reported adverse effects have been few. The longest study so far on the supplement lasted only 51 days. Gastrointestinal upset, muscle cramping, and dehydration have been anecdotally cited as the more prominent side effects. A case report in the Lancet suggested that the supplement can cause renal failure, but the patient had pre-existing kidney disease (Lancet, 1998;351:1252-3).

Last year creatine was implicated in the deaths of three college wrestlers but was subsequently cleared by the Food and Drug Administration of that suspicion. None the less, in July the administration warned consumers to consult a doctor before taking creatine, and it is investigating whether a link exists between the supplement and the development of seizures and brain tumours.

AP PHOTO/AMY SANCETTA
Mark McGwire uses performance enhancing drugs -- are they safe?

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Silver, M. D. (2001). Use of Ergogenic Aids by Athletes. J Am Acad Orthop Surg 9: 61-70 [Abstract] [Full text]  



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview